Anthony Kicic profile

Anthony Kicic

Associate Professor Kicic completed his undergraduate and doctorate degrees at the University of Western Australia, specializing in Molecular Biology and Cell Biology. His research interests lie in tissue engineering and reparative cell biology, particularly focusing on the ability of the cells in the body to repair, including stem cells. His research focuses on the role of the airway epithelium in the pathogenesis of a number of respiratory diseases including childhood asthma, cystic fibrosis and lung transplant rejection. In addition, he has a long-standing research platform in the field of host-pathogen interactions in chronic disease.  Associate Professor Kicic began working with phage and their potential to treat lung infections in 2016 and since then has led the WA phage research and translation pipeline, including establishing the largest phage library, with over 2000 phages specific to several types of bacteria including Pseudomonas aeruginosa (P. aeruginosa), Staphylococcus aureus (S. aureus) Burkholderia cenocepacia (B. cenocepacia), and Acinetobacter baumannii (A. baumannii). Associate Professor Kicic is often seen sampling Perth’s waterways for more superhero phage! 


Twitter | July 05, 2022
FundingPhage Therapy
News | June 17, 2022 | Phage WA

Leading the fight against Antimicrobial Resistance (AMR) in Western Australia: The WA Phage website showcases the research journey and outputs of WA researchers from the Wal-yan Respiratory Research Centre at the Telethon Kids Institute. The Phage WA website connects us with our community and provides up to date information on our collective mission to tackle anti-microbial resistance (AMR) through phage therapy.

Publication | September, 2021
Review paperRespiratory Tract infectionsPhage Therapy
Publication | November, 2021
Phage host rangePseudomonasScreening assayResearch paper
© 2024 Phage Australia